A sleeve diet plan involves gradual dietary progression after surgery, focusing on protein-rich foods, minimal carbohydrates, and small portion sizes. Long-term, patients must continue eating nutrient-dense, low-calorie meals to maintain weight loss. Key components include lean meats, vegetables, whole grains, and avoiding sugary and fatty foods.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

Metastatic gastric cancer occurs when stomach cancer spreads to other parts of the body, such as the liver, lungs, or lymph nodes. Treatment for metastatic gastric cancer often involves a combination of chemotherapy, radiation, and targeted therapies, as surgery is typically not an option for advanced-stage cancers.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

The long-term effects of sleeve gastrectomy include sustained weight loss, improvement or resolution of obesity-related conditions such as type 2 diabetes, hypertension, and sleep apnea. However, patients may also experience long-term nutritional deficiencies, requiring them to take supplements like vitamin B12, calcium, and iron. Regular follow-up with healthcare providers is essential to monitor these effects.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

Gastric sleeve results are typically impressive, with patients losing 50-60% of their excess body weight within the first year. The surgery also leads to improvements in obesity-related conditions like diabetes, hypertension, and sleep apnea. Long-term success depends on the patient’s ability to maintain a healthy lifestyle post-surgery.

The lap band and sleeve gastrectomy are two different bariatric surgeries. The lap band is adjustable and reversible, involving the placement of a band around the upper stomach. The sleeve, on the other hand, is permanent and involves the removal of part of the stomach. Sleeve gastrectomy tends to offer more substantial long-term weight loss, but the lap band has fewer immediate risks.

A gastric balloon is a non-surgical weight-loss option where a silicone balloon is inserted into the stomach and inflated. It takes up space, helping patients feel fuller sooner and eat less. The balloon is temporary and is removed after 6-12 months, during which patients must follow a strict diet and exercise regimen to ensure lasting weight loss.

Abdominal cancer refers to any malignant tumor in the abdomen, including stomach, liver, pancreatic, or colon cancer. Symptoms vary but may include unexplained weight loss, abdominal pain, and changes in bowel habits. Early detection is crucial for successful treatment, which may involve surgery, chemotherapy, or radiation.